Industry Research Reports

Home > Reports > Pharma & Healthcare > Knee Osteoarthritis Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Knee Osteoarthritis Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Pharma & Healthcare

Published: 2024-01-11

Pages: 108 Pages

Report ld: 2622781

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

Knee osteoarthritis or degenerative arthritis of the knee is the inflammation of the knee joints. It is a wear and tear, degenerative type of arthritis that is generally affects individuals above the age of 50 years; however, it can also occur in younger individuals. The cartilage in the knee joint gradual wears away in knee osteoarthritis. The knee joint becomes frayed and rough as the protective space in-between the bones reduces as the cartilage wears off. This causes friction in between the bones, which leads to painful bone spurs. The most common cause of this condition include age, rising weight, inherited abnormalities, repetitive stress injuries, heavy & stressful activities, and other illnesses such as rheumatoid arthritis and metabolic disorders. Symptoms of this conditions include swelling, warmth sensation in the joint, knee stiffness, and decrease in mobility.

The global market for Knee Osteoarthritis Treatment was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Knee Osteoarthritis Treatment, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Knee Osteoarthritis Treatment by region & country, by Type, and by Application.

The Knee Osteoarthritis Treatment market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Knee Osteoarthritis Treatment.

Market Segmentation

Report Metric
Details
Report Title
Knee Osteoarthritis Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global Knee Osteoarthritis Treatment Companies Covered
Bioventus, AVM Biotechnology, Anika Therapeutics, Flexion Therapeutics, OrthoTrophix, Sanofi, Horizon Therapeutics, Johnson and Johnson, GlaxoSmithKline, Bayer, Abbott, Pfizer, Eli Lilly
Global Knee Osteoarthritis Treatment Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Knee Osteoarthritis Treatment Market, Segment by Type
Non-surgical Treatment

Surgical Treatment
Global Knee Osteoarthritis Treatment Market, Segment by Application
Hospitals

Ambulatory Surgical Centers

Specialty Clinics

Others
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Knee Osteoarthritis Treatment manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Knee Osteoarthritis Treatment in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Knee Osteoarthritis Treatment in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Knee Osteoarthritis Treatment Product Introduction
    1.2 Global Knee Osteoarthritis Treatment Market Size Forecast
    1.3 Knee Osteoarthritis Treatment Market Trends & Drivers
        1.3.1 Knee Osteoarthritis Treatment Industry Trends
        1.3.2 Knee Osteoarthritis Treatment Market Drivers & Opportunity
        1.3.3 Knee Osteoarthritis Treatment Market Challenges
        1.3.4 Knee Osteoarthritis Treatment Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Knee Osteoarthritis Treatment Players Revenue Ranking (2023)
    2.2 Global Knee Osteoarthritis Treatment Revenue by Company (2019-2024)
    2.3 Key Companies Knee Osteoarthritis Treatment Manufacturing Base Distribution and Headquarters
    2.4 Key Companies Knee Osteoarthritis Treatment Product Offered
    2.5 Key Companies Time to Begin Mass Production of Knee Osteoarthritis Treatment
    2.6 Knee Osteoarthritis Treatment Market Competitive Analysis
        2.6.1 Knee Osteoarthritis Treatment Market Concentration Rate (2019-2024)
        2.6.2 Global 5 and 10 Largest Companies by Knee Osteoarthritis Treatment Revenue in 2023
        2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Knee Osteoarthritis Treatment as of 2023)
    2.7 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Non-surgical Treatment
        3.1.2 Surgical Treatment
    3.2 Global Knee Osteoarthritis Treatment Sales Value by Type
        3.2.1 Global Knee Osteoarthritis Treatment Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Knee Osteoarthritis Treatment Sales Value, by Type (2019-2030)
        3.2.3 Global Knee Osteoarthritis Treatment Sales Value, by Type (%) (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Hospitals
        4.1.2 Ambulatory Surgical Centers
        4.1.3 Specialty Clinics
        4.1.4 Others
    4.2 Global Knee Osteoarthritis Treatment Sales Value by Application
        4.2.1 Global Knee Osteoarthritis Treatment Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Knee Osteoarthritis Treatment Sales Value, by Application (2019-2030)
        4.2.3 Global Knee Osteoarthritis Treatment Sales Value, by Application (%) (2019-2030)

 5 Segmentation by Region
    5.1 Global Knee Osteoarthritis Treatment Sales Value by Region
        5.1.1 Global Knee Osteoarthritis Treatment Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Knee Osteoarthritis Treatment Sales Value by Region (2019-2024)
        5.1.3 Global Knee Osteoarthritis Treatment Sales Value by Region (2025-2030)
        5.1.4 Global Knee Osteoarthritis Treatment Sales Value by Region (%), (2019-2030)
    5.2 North America
        5.2.1 North America Knee Osteoarthritis Treatment Sales Value, 2019-2030
        5.2.2 North America Knee Osteoarthritis Treatment Sales Value by Country (%), 2023 VS 2030
    5.3 Europe
        5.3.1 Europe Knee Osteoarthritis Treatment Sales Value, 2019-2030
        5.3.2 Europe Knee Osteoarthritis Treatment Sales Value by Country (%), 2023 VS 2030
    5.4 Asia Pacific
        5.4.1 Asia Pacific Knee Osteoarthritis Treatment Sales Value, 2019-2030
        5.4.2 Asia Pacific Knee Osteoarthritis Treatment Sales Value by Country (%), 2023 VS 2030
    5.5 South America
        5.5.1 South America Knee Osteoarthritis Treatment Sales Value, 2019-2030
        5.5.2 South America Knee Osteoarthritis Treatment Sales Value by Country (%), 2023 VS 2030
    5.6 Middle East & Africa
        5.6.1 Middle East & Africa Knee Osteoarthritis Treatment Sales Value, 2019-2030
        5.6.2 Middle East & Africa Knee Osteoarthritis Treatment Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Knee Osteoarthritis Treatment Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Knee Osteoarthritis Treatment Sales Value
    6.3 United States
        6.3.1 United States Knee Osteoarthritis Treatment Sales Value, 2019-2030
        6.3.2 United States Knee Osteoarthritis Treatment Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Knee Osteoarthritis Treatment Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Knee Osteoarthritis Treatment Sales Value, 2019-2030
        6.4.2 Europe Knee Osteoarthritis Treatment Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Knee Osteoarthritis Treatment Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Knee Osteoarthritis Treatment Sales Value, 2019-2030
        6.5.2 China Knee Osteoarthritis Treatment Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Knee Osteoarthritis Treatment Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Knee Osteoarthritis Treatment Sales Value, 2019-2030
        6.6.2 Japan Knee Osteoarthritis Treatment Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Knee Osteoarthritis Treatment Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Knee Osteoarthritis Treatment Sales Value, 2019-2030
        6.7.2 South Korea Knee Osteoarthritis Treatment Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Knee Osteoarthritis Treatment Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Knee Osteoarthritis Treatment Sales Value, 2019-2030
        6.8.2 Southeast Asia Knee Osteoarthritis Treatment Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Knee Osteoarthritis Treatment Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Knee Osteoarthritis Treatment Sales Value, 2019-2030
        6.9.2 India Knee Osteoarthritis Treatment Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Knee Osteoarthritis Treatment Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Bioventus
        7.1.1 Bioventus Profile
        7.1.2 Bioventus Main Business
        7.1.3 Bioventus Knee Osteoarthritis Treatment Products, Services and Solutions
        7.1.4 Bioventus Knee Osteoarthritis Treatment Revenue (US$ Million) & (2019-2024)
        7.1.5 Bioventus Recent Developments
    7.2 AVM Biotechnology
        7.2.1 AVM Biotechnology Profile
        7.2.2 AVM Biotechnology Main Business
        7.2.3 AVM Biotechnology Knee Osteoarthritis Treatment Products, Services and Solutions
        7.2.4 AVM Biotechnology Knee Osteoarthritis Treatment Revenue (US$ Million) & (2019-2024)
        7.2.5 AVM Biotechnology Recent Developments
    7.3 Anika Therapeutics
        7.3.1 Anika Therapeutics Profile
        7.3.2 Anika Therapeutics Main Business
        7.3.3 Anika Therapeutics Knee Osteoarthritis Treatment Products, Services and Solutions
        7.3.4 Anika Therapeutics Knee Osteoarthritis Treatment Revenue (US$ Million) & (2019-2024)
        7.3.5 Flexion Therapeutics Recent Developments
    7.4 Flexion Therapeutics
        7.4.1 Flexion Therapeutics Profile
        7.4.2 Flexion Therapeutics Main Business
        7.4.3 Flexion Therapeutics Knee Osteoarthritis Treatment Products, Services and Solutions
        7.4.4 Flexion Therapeutics Knee Osteoarthritis Treatment Revenue (US$ Million) & (2019-2024)
        7.4.5 Flexion Therapeutics Recent Developments
    7.5 OrthoTrophix
        7.5.1 OrthoTrophix Profile
        7.5.2 OrthoTrophix Main Business
        7.5.3 OrthoTrophix Knee Osteoarthritis Treatment Products, Services and Solutions
        7.5.4 OrthoTrophix Knee Osteoarthritis Treatment Revenue (US$ Million) & (2019-2024)
        7.5.5 OrthoTrophix Recent Developments
    7.6 Sanofi
        7.6.1 Sanofi Profile
        7.6.2 Sanofi Main Business
        7.6.3 Sanofi Knee Osteoarthritis Treatment Products, Services and Solutions
        7.6.4 Sanofi Knee Osteoarthritis Treatment Revenue (US$ Million) & (2019-2024)
        7.6.5 Sanofi Recent Developments
    7.7 Horizon Therapeutics
        7.7.1 Horizon Therapeutics Profile
        7.7.2 Horizon Therapeutics Main Business
        7.7.3 Horizon Therapeutics Knee Osteoarthritis Treatment Products, Services and Solutions
        7.7.4 Horizon Therapeutics Knee Osteoarthritis Treatment Revenue (US$ Million) & (2019-2024)
        7.7.5 Horizon Therapeutics Recent Developments
    7.8 Johnson and Johnson
        7.8.1 Johnson and Johnson Profile
        7.8.2 Johnson and Johnson Main Business
        7.8.3 Johnson and Johnson Knee Osteoarthritis Treatment Products, Services and Solutions
        7.8.4 Johnson and Johnson Knee Osteoarthritis Treatment Revenue (US$ Million) & (2019-2024)
        7.8.5 Johnson and Johnson Recent Developments
    7.9 GlaxoSmithKline
        7.9.1 GlaxoSmithKline Profile
        7.9.2 GlaxoSmithKline Main Business
        7.9.3 GlaxoSmithKline Knee Osteoarthritis Treatment Products, Services and Solutions
        7.9.4 GlaxoSmithKline Knee Osteoarthritis Treatment Revenue (US$ Million) & (2019-2024)
        7.9.5 GlaxoSmithKline Recent Developments
    7.10 Bayer
        7.10.1 Bayer Profile
        7.10.2 Bayer Main Business
        7.10.3 Bayer Knee Osteoarthritis Treatment Products, Services and Solutions
        7.10.4 Bayer Knee Osteoarthritis Treatment Revenue (US$ Million) & (2019-2024)
        7.10.5 Bayer Recent Developments
    7.11 Abbott
        7.11.1 Abbott Profile
        7.11.2 Abbott Main Business
        7.11.3 Abbott Knee Osteoarthritis Treatment Products, Services and Solutions
        7.11.4 Abbott Knee Osteoarthritis Treatment Revenue (US$ Million) & (2019-2024)
        7.11.5 Abbott Recent Developments
    7.12 Pfizer
        7.12.1 Pfizer Profile
        7.12.2 Pfizer Main Business
        7.12.3 Pfizer Knee Osteoarthritis Treatment Products, Services and Solutions
        7.12.4 Pfizer Knee Osteoarthritis Treatment Revenue (US$ Million) & (2019-2024)
        7.12.5 Pfizer Recent Developments
    7.13 Eli Lilly
        7.13.1 Eli Lilly Profile
        7.13.2 Eli Lilly Main Business
        7.13.3 Eli Lilly Knee Osteoarthritis Treatment Products, Services and Solutions
        7.13.4 Eli Lilly Knee Osteoarthritis Treatment Revenue (US$ Million) & (2019-2024)
        7.13.5 Eli Lilly Recent Developments

 8 Industry Chain Analysis
    8.1 Knee Osteoarthritis Treatment Industrial Chain
    8.2 Knee Osteoarthritis Treatment Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Knee Osteoarthritis Treatment Sales Model
        8.5.2 Sales Channel
        8.5.3 Knee Osteoarthritis Treatment Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Knee Osteoarthritis Treatment Market Trends
    Table 2. Knee Osteoarthritis Treatment Market Drivers & Opportunity
    Table 3. Knee Osteoarthritis Treatment Market Challenges
    Table 4. Knee Osteoarthritis Treatment Market Restraints
    Table 5. Global Knee Osteoarthritis Treatment Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Knee Osteoarthritis Treatment Revenue Market Share by Company (2019-2024)
    Table 7. Key Companies Knee Osteoarthritis Treatment Manufacturing Base Distribution and Headquarters
    Table 8. Key Companies Knee Osteoarthritis Treatment Product Type
    Table 9. Key Companies Time to Begin Mass Production of Knee Osteoarthritis Treatment
    Table 10. Global Knee Osteoarthritis Treatment Companies Market Concentration Ratio (CR5 and HHI)
    Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Knee Osteoarthritis Treatment as of 2023)
    Table 12. Mergers & Acquisitions, Expansion Plans
    Table 13. Global Knee Osteoarthritis Treatment Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 14. Global Knee Osteoarthritis Treatment Sales Value by Type (2019-2024) & (US$ Million)
    Table 15. Global Knee Osteoarthritis Treatment Sales Value by Type (2025-2030) & (US$ Million)
    Table 16. Global Knee Osteoarthritis Treatment Sales Market Share in Value by Type (2019-2024) & (%)
    Table 17. Global Knee Osteoarthritis Treatment Sales Market Share in Value by Type (2025-2030) & (%)
    Table 18. Global Knee Osteoarthritis Treatment Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 19. Global Knee Osteoarthritis Treatment Sales Value by Application (2019-2024) & (US$ Million)
    Table 20. Global Knee Osteoarthritis Treatment Sales Value by Application (2025-2030) & (US$ Million)
    Table 21. Global Knee Osteoarthritis Treatment Sales Market Share in Value by Application (2019-2024) & (%)
    Table 22. Global Knee Osteoarthritis Treatment Sales Market Share in Value by Application (2025-2030) & (%)
    Table 23. Global Knee Osteoarthritis Treatment Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 24. Global Knee Osteoarthritis Treatment Sales Value by Region (2019-2024) & (US$ Million)
    Table 25. Global Knee Osteoarthritis Treatment Sales Value by Region (2025-2030) & (US$ Million)
    Table 26. Global Knee Osteoarthritis Treatment Sales Value by Region (2019-2024) & (%)
    Table 27. Global Knee Osteoarthritis Treatment Sales Value by Region (2025-2030) & (%)
    Table 28. Key Countries/Regions Knee Osteoarthritis Treatment Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 29. Key Countries/Regions Knee Osteoarthritis Treatment Sales Value, (2019-2024) & (US$ Million)
    Table 30. Key Countries/Regions Knee Osteoarthritis Treatment Sales Value, (2025-2030) & (US$ Million)
    Table 31. Bioventus Basic Information List
    Table 32. Bioventus Description and Business Overview
    Table 33. Bioventus Knee Osteoarthritis Treatment Products, Services and Solutions
    Table 34. Revenue (US$ Million) in Knee Osteoarthritis Treatment Business of Bioventus (2019-2024)
    Table 35. Bioventus Recent Developments
    Table 36. AVM Biotechnology Basic Information List
    Table 37. AVM Biotechnology Description and Business Overview
    Table 38. AVM Biotechnology Knee Osteoarthritis Treatment Products, Services and Solutions
    Table 39. Revenue (US$ Million) in Knee Osteoarthritis Treatment Business of AVM Biotechnology (2019-2024)
    Table 40. AVM Biotechnology Recent Developments
    Table 41. Anika Therapeutics Basic Information List
    Table 42. Anika Therapeutics Description and Business Overview
    Table 43. Anika Therapeutics Knee Osteoarthritis Treatment Products, Services and Solutions
    Table 44. Revenue (US$ Million) in Knee Osteoarthritis Treatment Business of Anika Therapeutics (2019-2024)
    Table 45. Anika Therapeutics Recent Developments
    Table 46. Flexion Therapeutics Basic Information List
    Table 47. Flexion Therapeutics Description and Business Overview
    Table 48. Flexion Therapeutics Knee Osteoarthritis Treatment Products, Services and Solutions
    Table 49. Revenue (US$ Million) in Knee Osteoarthritis Treatment Business of Flexion Therapeutics (2019-2024)
    Table 50. Flexion Therapeutics Recent Developments
    Table 51. OrthoTrophix Basic Information List
    Table 52. OrthoTrophix Description and Business Overview
    Table 53. OrthoTrophix Knee Osteoarthritis Treatment Products, Services and Solutions
    Table 54. Revenue (US$ Million) in Knee Osteoarthritis Treatment Business of OrthoTrophix (2019-2024)
    Table 55. OrthoTrophix Recent Developments
    Table 56. Sanofi Basic Information List
    Table 57. Sanofi Description and Business Overview
    Table 58. Sanofi Knee Osteoarthritis Treatment Products, Services and Solutions
    Table 59. Revenue (US$ Million) in Knee Osteoarthritis Treatment Business of Sanofi (2019-2024)
    Table 60. Sanofi Recent Developments
    Table 61. Horizon Therapeutics Basic Information List
    Table 62. Horizon Therapeutics Description and Business Overview
    Table 63. Horizon Therapeutics Knee Osteoarthritis Treatment Products, Services and Solutions
    Table 64. Revenue (US$ Million) in Knee Osteoarthritis Treatment Business of Horizon Therapeutics (2019-2024)
    Table 65. Horizon Therapeutics Recent Developments
    Table 66. Johnson and Johnson Basic Information List
    Table 67. Johnson and Johnson Description and Business Overview
    Table 68. Johnson and Johnson Knee Osteoarthritis Treatment Products, Services and Solutions
    Table 69. Revenue (US$ Million) in Knee Osteoarthritis Treatment Business of Johnson and Johnson (2019-2024)
    Table 70. Johnson and Johnson Recent Developments
    Table 71. GlaxoSmithKline Basic Information List
    Table 72. GlaxoSmithKline Description and Business Overview
    Table 73. GlaxoSmithKline Knee Osteoarthritis Treatment Products, Services and Solutions
    Table 74. Revenue (US$ Million) in Knee Osteoarthritis Treatment Business of GlaxoSmithKline (2019-2024)
    Table 75. GlaxoSmithKline Recent Developments
    Table 76. Bayer Basic Information List
    Table 77. Bayer Description and Business Overview
    Table 78. Bayer Knee Osteoarthritis Treatment Products, Services and Solutions
    Table 79. Revenue (US$ Million) in Knee Osteoarthritis Treatment Business of Bayer (2019-2024)
    Table 80. Bayer Recent Developments
    Table 81. Abbott Basic Information List
    Table 82. Abbott Description and Business Overview
    Table 83. Abbott Knee Osteoarthritis Treatment Products, Services and Solutions
    Table 84. Revenue (US$ Million) in Knee Osteoarthritis Treatment Business of Abbott (2019-2024)
    Table 85. Abbott Recent Developments
    Table 86. Pfizer Basic Information List
    Table 87. Pfizer Description and Business Overview
    Table 88. Pfizer Knee Osteoarthritis Treatment Products, Services and Solutions
    Table 89. Revenue (US$ Million) in Knee Osteoarthritis Treatment Business of Pfizer (2019-2024)
    Table 90. Pfizer Recent Developments
    Table 91. Eli Lilly Basic Information List
    Table 92. Eli Lilly Description and Business Overview
    Table 93. Eli Lilly Knee Osteoarthritis Treatment Products, Services and Solutions
    Table 94. Revenue (US$ Million) in Knee Osteoarthritis Treatment Business of Eli Lilly (2019-2024)
    Table 95. Eli Lilly Recent Developments
    Table 96. Key Raw Materials Lists
    Table 97. Raw Materials Key Suppliers Lists
    Table 98. Knee Osteoarthritis Treatment Downstream Customers
    Table 99. Knee Osteoarthritis Treatment Distributors List
    Table 100. Research Programs/Design for This Report
    Table 101. Key Data Information from Secondary Sources
    Table 102. Key Data Information from Primary Sources
    Table 103. Business Unit and Senior & Team Lead Analysts
List of Figures
    Figure 1. Knee Osteoarthritis Treatment Product Picture
    Figure 2. Global Knee Osteoarthritis Treatment Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Knee Osteoarthritis Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 4. Knee Osteoarthritis Treatment Report Years Considered
    Figure 5. Global Knee Osteoarthritis Treatment Players Revenue Ranking (2023) & (US$ Million)
    Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Knee Osteoarthritis Treatment Revenue in 2023
    Figure 7. Knee Osteoarthritis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 8. Non-surgical Treatment Picture
    Figure 9. Surgical Treatment Picture
    Figure 10. Global Knee Osteoarthritis Treatment Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 11. Global Knee Osteoarthritis Treatment Sales Value Market Share by Type, 2023 & 2030
    Figure 12. Product Picture of Hospitals
    Figure 13. Product Picture of Ambulatory Surgical Centers
    Figure 14. Product Picture of Specialty Clinics
    Figure 15. Product Picture of Others
    Figure 16. Global Knee Osteoarthritis Treatment Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 17. Global Knee Osteoarthritis Treatment Sales Value Market Share by Application, 2023 & 2030
    Figure 18. North America Knee Osteoarthritis Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 19. North America Knee Osteoarthritis Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 20. Europe Knee Osteoarthritis Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 21. Europe Knee Osteoarthritis Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 22. Asia Pacific Knee Osteoarthritis Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 23. Asia Pacific Knee Osteoarthritis Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 24. South America Knee Osteoarthritis Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 25. South America Knee Osteoarthritis Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 26. Middle East & Africa Knee Osteoarthritis Treatment Sales Value (2019-2030) & (US$ Million)
    Figure 27. Middle East & Africa Knee Osteoarthritis Treatment Sales Value by Country (%), 2023 VS 2030
    Figure 28. Key Countries/Regions Knee Osteoarthritis Treatment Sales Value (%), (2019-2030)
    Figure 29. United States Knee Osteoarthritis Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 30. United States Knee Osteoarthritis Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 31. United States Knee Osteoarthritis Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 32. Europe Knee Osteoarthritis Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 33. Europe Knee Osteoarthritis Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 34. Europe Knee Osteoarthritis Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 35. China Knee Osteoarthritis Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 36. China Knee Osteoarthritis Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 37. China Knee Osteoarthritis Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 38. Japan Knee Osteoarthritis Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 39. Japan Knee Osteoarthritis Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 40. Japan Knee Osteoarthritis Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 41. South Korea Knee Osteoarthritis Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 42. South Korea Knee Osteoarthritis Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 43. South Korea Knee Osteoarthritis Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 44. Southeast Asia Knee Osteoarthritis Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 45. Southeast Asia Knee Osteoarthritis Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 46. Southeast Asia Knee Osteoarthritis Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 47. India Knee Osteoarthritis Treatment Sales Value, (2019-2030) & (US$ Million)
    Figure 48. India Knee Osteoarthritis Treatment Sales Value by Type (%), 2023 VS 2030
    Figure 49. India Knee Osteoarthritis Treatment Sales Value by Application (%), 2023 VS 2030
    Figure 50. Knee Osteoarthritis Treatment Industrial Chain
    Figure 51. Knee Osteoarthritis Treatment Manufacturing Cost Structure
    Figure 52. Channels of Distribution (Direct Sales, and Distribution)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation

Description

Knee osteoarthritis or degenerative arthritis of the knee is the inflammation of the knee joints. It is a wear and tear, degenerative type of arthritis that is generally affects individuals above the age of 50 years; however, it can also occur in younger individuals. The cartilage in the knee joint gradual wears away in knee osteoarthritis. The knee joint becomes frayed and rough as the protective space in-between the bones reduces as the cartilage wears off. This causes friction in between the bones, which leads to painful bone spurs. The most common cause of this condition include age, rising weight, inherited abnormalities, repetitive stress injuries, heavy & stressful activities, and other illnesses such as rheumatoid arthritis and metabolic disorders. Symptoms of this conditions include swelling, warmth sensation in the joint, knee stiffness, and decrease in mobility.

The global market for Knee Osteoarthritis Treatment was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

Market Segmentation